- Challenging the Status Quo: The History, Science, and Psychology Behind NAM Validation
-
Room 301‚ Convention Center
Chair: Russell Thomas, UL Research Institutes Chemical Insights
Co-Chair: Warren Casey, NIEHS
Primary Endorser: In Vitro and Alternative Methods Specialty Section
Endorser(s): Computational Toxicology Specialty Section
Endorser(s): Regulatory and Safety Evaluation Specialty SectionEstablishing performance expectations and validating New Approach Methodologies (NAMs) in toxicity testing presents complex challenges spanning both scientific, regulatory and psychological dimensions. Traditional animal-based methods have long served as the foundation for predicting human health effects and remain the standard for many toxicological endpoints; however, many have not undergone formal validation that include ring trials, and their concordance with human outcomes and inter-study variability are not well characterized. From a scientific perspective, the lack of rigorous validation, consideration of human relevance, and variability limits the ability to define objective benchmarks, potentially leading to unrealistic expectations for NAM performance. Developers of NAMs face a fundamental challenge when regulatory authorities require direct comparison to legacy animal test guidelines, effectively forcing these potentially more human-relevant methods to align with animal data and creating a paradox where NAMs cannot demonstrate superiority without first “matching” results from models they are intended to replace. From a psychological perspective, animal-based methods represent a familiar uncertainty which are often preferred over less familiar approaches such as NAMs, even when their human relevance or overall performance may be inferior. The complex topic will be addressed through a panel discussion with experts in each of the different dimensions. The panel will briefly examine realistic benchmarks for NAMs by comparing the historical validation characteristics of both in vivo and in vitro human health test guidelines, summarize the results from studies evaluating the variability of in vivo toxicity studies to identify hazards and associated effect levels, and investigate the concordance of rodent toxicity data and in vitro NAMs with human clinical trial outcomes. The panel will build on the benchmarks to explore how performance data, animal studies, and human evidence have been integrated into real-world validation efforts and examine the psychological factors that influence perceptions of chemical risk and the acceptance of new testing methods. The session will conclude with a panel discussion and audience participation that synthesizes how these historical, scientific, and psychological perspectives highlight the need to shift from a predictive to a protective paradigm for NAM validation and application, while also identifying critical gaps that must be addressed to advance the field.
Session and Activity Type
Enter Note
Go to previous page in this tab
Event
